Erratum to: nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma: Canadian Subgroup Analysis of the Phase 3 MPACT Trial

Advances in Therapy - Tập 34 - Trang 277-279 - 2016
Mustapha Tehfe1, Scot Dowden2, Hagen Kennecke3, Robert El-Maraghi4, Bernard Lesperance5, Felix Couture6, Richard Letourneau1, Helen Liu7, Alfredo Romano7
1Centre hospitalier de l’Université de Montréal (CHUM), Montreal, Canada
2Tom Baker Cancer Centre, Calgary, Canada
3British Columbia Cancer Agency, Vancouver, Canada
4Royal Victoria Regional Health Centre, Barrie, Canada
5Hôpital du Sacré-Coeur de Montreal, Montreal, Canada
6Centre hospitalier universitaire de Québec (CHUQ), Hôtel-Dieu de Quebec, CHUM, Montreal, Canada
7Celgene Corporation, Summit, USA

Thông tin
Thông tin xuất bản

Advances in Therapy

Tập 34

277-279

Thông tin tác giả